Ensysce Biosciences shares are trading lower. The company announced the publication of first clinical manuscript describing its Multi-Pill Abuse Resistance overdose protection technology.

Ensysce Biosciences, Inc. -5.66% Pre

Ensysce Biosciences, Inc.

ENSC

0.52

0.49

-5.66%

-5.60% Pre
Ensysce Biosciences shares are trading lower. The company announced the publication of first clinical manuscript describing its Multi-Pill Abuse Resistance overdose protection technology.